Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
about
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and LipidomicsApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacityGenotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical OutcomesSerum amyloid A impairs the antiinflammatory properties of HDLProteomic analysis of HDL from inbred mouse strains implicates APOE associated with HDL in reduced cholesterol efflux capacity via the ABCA1 pathwayStructure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks.Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.Dysfunctional HDL and atherosclerotic cardiovascular disease.Influence of HDL particles on cell-cholesterol efflux under various pathological conditions.Inflammation, remodeling, and other factors affecting HDL cholesterol efflux.Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure.Further evidence that high-density lipoprotein is a chameleon-like lipoprotein.Depletion of HDL3 high density lipoprotein and altered functionality of HDL2 in blood from sickle cell patients.Multiphoton-Polymerized 3D Protein Assay.HDL Particle Size and Functional Heterogeneity.Changes in High-Density Lipoprotein Cholesterol Efflux Capacity After Bariatric Surgery Are Procedure Dependent.Quantifying HDL proteins by mass spectrometry: how many proteins are there and what are their functions?Novel Approaches for HDL-Directed Therapies.Time to ditch HDL-C as a measure of HDL function?CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients.Impact of Dietary Cholesterol on the Pathophysiology of Infectious and Autoimmune Disease.Plasma lipoproteome in Alzheimer's disease: a proof-of-concept studyAttenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in miceApolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT mouse model of preeclampsiaCholesterol efflux responds to viral load and CD4 counts in HIV+ patients and is dampened in HIV exposed
P2860
Q26774903-D09DDEF5-9BB9-413A-A2A6-748F556657ACQ33725659-357DAC6D-6A87-4C47-A021-8A767536EA71Q34534212-B7A1EA20-C7AE-4A7C-9B6F-91906B17FE4CQ36430779-1E15694C-672B-4A01-AE41-D66916B383F1Q36503826-387BC1B5-7C0C-4CBF-A7CA-6305DC01D67CQ36723137-F5011417-2D6D-4243-9731-1F0211A4104EQ37251396-0768811D-06B9-4931-8D97-846A295C7014Q38377434-9BC87E99-E2B5-46B8-B7DE-AB723B868425Q38436472-AEAC2B4C-45C0-4391-BAC2-ADCB5FFE37FDQ38577283-1DA24179-F353-4227-875B-9C3202E7ECD2Q38831490-3C0D980D-B204-4224-9320-3169909C936FQ39025753-8F39D598-4EC5-4D61-9247-2AD01958A2CFQ40083837-81AB6A80-A8B6-4A3D-BD47-6AB185A5DD63Q41389933-07C35EB5-E20D-47F2-9C1F-1C9AFBF95225Q42874127-6895C57E-60AB-4E1B-B148-9829DD3BB312Q44730398-DCA0130D-CE0A-4D93-B682-F125DF985B41Q47252330-E62031F9-F5AF-4CDD-BDEA-E18EA862AED9Q47276390-7BFDF99E-D255-47F9-BCFB-6579CA4CC430Q47377594-D64FC491-5EBD-4CE4-B2D7-69A83784B517Q47429427-E2F397E6-D7E6-47DF-97DD-112698A1D08CQ47441104-1CA230F3-1098-4487-A391-3C967D8016B3Q47991245-E3AEC753-8391-45C9-80E2-E99CF32D20EFQ50044467-4F59A5B5-2B2A-4791-A3D7-DD1AB51EB7C0Q55420511-0B0A0677-8F12-4946-B5B4-40B4EFE50E36Q55515189-A24EB959-7AEC-4070-B83A-85C4B3E71B33Q57153825-63C38887-2F91-4E61-B35F-0C173AA10D3BQ58737823-C6D093E2-2293-458D-A0AA-A882383C7134Q58737878-02639D30-B47F-4BAA-9463-18ADA70CC5CBQ58741972-43B12A66-C837-4FBE-9C44-3DCFFC89C0C8
P2860
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@ast
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@en
type
label
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@ast
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@en
prefLabel
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@ast
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@en
P2093
P2860
P356
P1476
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
@en
P2093
Anthony F Suffredini
Chongren Tang
Ilona Babenko
Jake Wimberger
Jay W Heinecke
Patrick Hutchins
Tomáš Vaisar
P2860
P304
P356
10.1194/JLR.M059089
P577
2015-05-20T00:00:00Z